Showing results (2521-2530 of 4,014) with videos related to

Sort By:
Pageof 402
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|March 10, 2006
The proteome: structure, function and evolutionKeiran Fleming, Lawrence A Kelley, Suhail A Islam, et al.
Journal of Paediatrics and Child Health|September 14, 2018
The role of skin testing and extended antibiotic courses in assessment of children with penicillin allergy: An Australian experienceAnnabelle Arnold, Aine Sommerfield, Anoop Ramgolam, et al.
Paediatric Anaesthesia|August 13, 2019
A framework for the management of the pediatric airwayThomas Engelhardt, John E Fiadjoe, Markus Weiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumorsC N Sternberg, P H de Mulder, A T van Oosterom, et al.
Annals of Neurology|September 25, 2004
Electromyography guides toward subgroups of mutations in muscle channelopathiesEmmanuel Fournier, Marianne Arzel, Damien Sternberg, et al.
Paediatric Anaesthesia|October 15, 2017
A prospective audit of pain profiles following general and urological surgery in childrenCaroline A Wilson, David Sommerfield, Thomas F E Drake-Brockman, et al.
Frontiers in Veterinary Science|December 15, 2015
African Swine Fever in Uganda: Qualitative Evaluation of Three Surveillance Methods with Implications for Other Resource-Poor SettingsErika Chenais, Susanna Sternberg-Lewerin, Sofia Boqvist, et al.
The Journal of Urology|November 22, 2017
Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer StudiesMarco Moschini, Shahrokh F Shariat, Morgan Rouprêt, et al.
European Journal of Cancer (Oxford, England : 1990)|March 17, 2018
Efficacy of tivozanib treatment after sorafenib in patients with advanced renal cell carcinoma: crossover of a phase 3 studyAna M Molina, Thomas E Hutson, Dmitry Nosov, et al.
Molecular and Cellular Biology|March 7, 2007
An activating mutation in sos-1 identifies its Dbl domain as a critical inhibitor of the epidermal growth factor receptor pathway during Caenorhabditis elegans vulval developmentKatarzyna Modzelewska, Marc G Elgort, Jingyu Huang, et al.
Pageof 402